StockNews.com upgraded shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) to a sell rating in a report issued on Saturday.
Aptevo Therapeutics Price Performance
Shares of NASDAQ:APVO opened at $2.64 on Friday. The stock has a 50 day moving average price of $3.80 and a 200-day moving average price of $166.20. Aptevo Therapeutics has a 52-week low of $2.35 and a 52-week high of $207.33.
Aptevo Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Aptevo Therapeutics
- Using the MarketBeat Dividend Tax Calculator
- Can TikTok Stock Picks Really Make You Rich?
- The Risks of Owning Bonds
- The “Quality” Rotation: Back to Basics Investing
- How to Most Effectively Use the MarketBeat Earnings Screener
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Aptevo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptevo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.